Giải phẫu bệnh trong các trường hợp nghi ngờ mắc COVID-19

Journal of Clinical Pathology - Tập 73 Số 5 - Trang 239-242 - 2020
Brian Hanley1, Sebastian Lucas2, Esther Youd3, Benjamin Swift4, Michael Osborn5
1Cellular Pathology, Imperial College London NHS Trust, London, UK
2Department of Histopathology, GKT, Medical school in London, London, UK
3Department of Histopathology, Cwm Taf Morgannwg Health Board, Llantrisant, UK
4Forensic Pathology Services, Oxon, UK
5Department of Cellular Pathology, Imperial College London NHS Trust, London, UK

Tóm tắt

Sự bùng phát của hội chứng hô hấp cấp tính nghiêm trọng (SARS)-coronavirus-2 (CoV-2) ở Vũ Hán, Trung Quốc hiện đã lan ra nhiều quốc gia trên toàn thế giới, bao gồm cả Vương quốc Anh, với số lượng tử vong ngày càng tăng. Điều này chắc chắn sẽ dẫn đến sự gia tăng số lượng trường hợp nghi ngờ tử vong liên quan đến bệnh coronavirus 2019 (COVID-19) tại các cuộc giải phẫu tử thi. Viện Hàn lâm Y học Hoàng gia đã đáp ứng mối lo ngại này bằng cách công bố một hướng dẫn về thực hành giải phẫu liên quan đến COVID-19. Bài viết sau đây là tóm tắt và diễn giải những hướng dẫn này. Nó bao gồm mô tả về các sinh vật nhóm nguy cơ 3, danh mục mà SARS-CoV-2 đã được phân loại, một mô tả ngắn gọn về những gì hiện đang được biết đến về các phát hiện về bệnh lý và giải phẫu trong COVID-19, tóm tắt các khuyến nghị cho việc thực hiện giải phẫu trong các trường hợp nghi ngờ mắc COVID-19 và các kỹ thuật để đưa ra chẩn đoán tại giải phẫu. Bài viết kết thúc bằng việc xem xét mối tương quan lâm sàng-bệnh lý và thông báo các trường hợp như vậy.

Từ khóa

#COVID-19 #giải phẫu #SARS-CoV-2 #bệnh lý #hướng dẫn

Tài liệu tham khảo

10.1056/NEJMp030078

World Health Organization . Director General's remarks at the media briefing on 2019-nCoV on 11 February 2020. secondary director General's remarks at the media briefing on 2019-nCoV on 11 February 2020, 2020. Available: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

European Centre for Disease Prevention and Control . Threats and outbreaks: COVID-19 secondary threats and outbreaks: COVID-19, 2020. Available: https://www.ecdc.europa.eu/en/novel-coronavirus-china

Osborn M , Lucas S , Stewart R , et al . Autopsy practice relating to possible cases of COVID-19 (2019-nCov, novel coronavirus from China 2019/2020) secondary autopsy practice relating to possible cases of COVID-19 (2019-nCov, novel coronavirus from China 2019/2020), 2020. Available: https://www.rcpath.org/uploads/assets/d5e28baf-5789-4b0f-acecfe370eee6223/fe8fa85a-f004-4a0c-81ee4b2b9cd12cbf/Briefing-on-COVID-19-autopsy-Feb-2020.pdf

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Wang D , Hu B , Hu C , et al . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020.doi:10.1001/jama.2020.1585

Health and Safety Executive Advisory Committee on Dangerous Pathogens . The Approved list of biological agents. secondary the Approved list of biological agents. Available: www.hse.gov.uk/pubns/misc208.pdf

Health and Safety Executive . Safe working and the prevention of infection in the mortuary and post-mortem room. secondary safe working and the prevention of infection in the mortuary and post-mortem room, 2018. Available: https://www.rcpath.org/uploads/assets/d5e28baf-5789-4b0f-acecfe370eee6223/fe8fa85a-f004-4a0c-81ee4b2b9cd12cbf/Briefing-on-COVID-19-autopsy-Feb-2020.pdf

Public Health England . COVID-19: safe handling and processing for laboratories secondary COVID-19: safe handling and processing for laboratories, 2020. Available: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories/wuhan-novel-coronavirus-handling-and-processing-of-laboratory-specimens

Xu Z , Shi L , Wang Y , et al . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine.

Tian, 2020, Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer, J Thorac Oncol

Public Health England . COVID-19: investigation and initial clinical management of possible cases. secondary COVID-19: investigation and initial clinical management of possible cases, 2020. Available: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection

10.1002/path.1440

10.1016/j.ajpath.2015.10.024

Lucas S . Autopsies on people with high-risk infections. In: The hospital autopsy: a manual of fundamental autopsy practice. 3rd edition. London, UK: Hodder Arnold, 2010.

NBS T . Hbn 20 facilities for mortuary and post-mortem room services (3rd edition). secondary HbN 20 facilities for mortuary and post-mortem room services (3rd edition), 2005. Available: www.thenbs.com/PublicationIndex/documents/details?Pub=NHS&DocID=275892

Castillo, 2016, Validity of a minimally invasive autopsy for cause of death determination in adults in Mozambique: an observational study, PLoS Med, 13, 10.1371/journal.pmed.1002171

Zhao, 2020, Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study, AJR Am J Roentgenol, 1

Public Health England . COVID-19: guidance for sampling and for diagnostic laboratories secondary COVID-19: guidance for sampling and for diagnostic laboratories, 2020. Available: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories

Henwood, 2020, Coronavirus disinfection in histopathology, J Histotechnol, 16, 1